Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ScanTech AI Systems Inc.STAI · Entity 8774 | VP and Chief Science Officer | May 02, 2025 | May 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ScanTech AI Systems Inc.
Report date May 02, 2025 · Filed May 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 440,176 |
Reported balance
After 2025-05-02 transaction · row 1
1 source rowRow 1 · 2025-05-02 · Grant · Acquired 402,073 · Balance 440,176 F1: Grant of shares upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of shares upon vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2025 Filed May 7, 2025 16:06 UTC | ScanTech AI Systems Inc. STAI · Entity 8774 | GrantCommon Stock | 402,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-045527 · tm2514137-4_4seq1.xml · nonDerivative · entry 1 Forbes Alfred IV · CIK 0002053821 · VP and Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,176 F1 · shares: Grant of shares upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.